TAGLN2 and cervical squamous cell carcinoma: In addition, the inhibition of TAGLN2 in human cervical squamous cell carcinoma (SCC) and uterine SCC cells has been shown to significantly inhibit tumor growth and invasion (Fukushima et al., 2011).